Cardiomyopathy is a leading cause of heart failure in children, and there are currently no effective treatments. Could emerging therapies that successfully target the root cause of the condition in adults also work well in children? That was the question Dr....
In the realm of cardiac health, an exciting new study has cast light on the intricate details of our hearts, revealing significant differences between the left and right ventricles' fibroblasts. This research, conducted by a team of dedicated scientists from the...
For children diagnosed with complex heart conditions like hypertrophic cardiomyopathy (HCM), the diagnosis can be frightening for families and challenging for healthcare providers since the trajectory of the condition is often uncertain. As a leading cause of sudden...
An innovative cardiovascular start-up, HDAX Therapeutics, is the latest company to win $250,000 in funding following another year of the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) program. The ECHO program...
Researchers at the Ted Rogers Centre for Heart Research have developed an innovative approach to better understanding the complex signaling mechanisms underlying heart failure. A recent publication in the Proceedings of the National Academy of Sciences (PNAS) offers...
The Rogers Foundation announces a second landmark gift, building on its $130 million gift in 2014, to sustain the Ted Rogers Centre for Heart Research in perpetuity and bring the promise of precision cardiac health to patients across Canada and globally. In 2014, the...
Several members of the Ted Rogers Centre for Heart Research (TRCHR) participated in Vascular 2023, a five-day conference held in Montreal from October 25-29. The conference is a hallmark event organized by several Canadian specialist and research organizations, occurring once a decade. This year’s event was hosted by the Canadian Cardiovascular Society, Canadian Society of Endocrinology and Metabolism, Canadian Venous Thromboembolism Research Network (CanVECTOR), Diabète Quebec, Diabetes Canada, and Thrombosis Canada.
TRCHR was well-represented at the conference, with our researchers and trainees actively engaged in poster presentations, delivering talks, and leading patient engagement workshops. Notably, the conference also witnessed the presentation of three prestigious Canadian Cardiovascular Society (CSS) Recognition Awards to deserving members of the TRCHR community. Each year, the CSS acknowledges remarkable achievements by both Canadian individuals and organizations in the field of cardiovascular health and care, recognizing excellence in research, education, patient care, cardiovascular disease prevention, and significant career contributions.
CSS Research Achievement Award
We are thrilled to announce that Dr. Douglas Lee, Ted Rogers Chair in Heart Function Outcomes, was presented with the CSS Research Achievement Award. This prestigious recognition, established in 1982, honors exceptional contributions to the field of cardiovascular research in Canada. Dr. Lee’s research interests include heart failure epidemiology, implantable cardioverter defibrillator utilization, cardiovascular disease risk factors and prevention, and quality of care and outcomes research. Dr. Douglas Lee is a professor of medicine at the University of Toronto, cardiologist at the University Health Network (UHN), and senior scientist and leader of the Cardiovascular Program at the Institute for Clinical Evaluative Sciences (ICES).
For more information on Dr. Lee’s research, please visit UHNresearch.ca.
Joint CANCARE Society & CCS Excellence in Cardiac Critical Care Research Award
We are very excited to announced that Dr. Ismail Raslan, Chief Clinical Fellow in Advanced Heart Failure and Transplant with the University Health Network, won the Joint CANCARE Society & CCS Excellence in Cardiac Critical Care Research Award. The award was created in 2015 to recognize excellence in cardiac critical care research. Dr. Raslan specializes in heart failure transplants and cardiac oncology research. He obtained a Master’s in Translational Medicine in Cardiology from the University of Alberta, then received specialized training in Internal Medicine at McGill University and Cardiology at the University of Toronto. Currently, he serves as a Board Member for the Canadian Heart Failure Society and an assistant professor at King Saud University.
CCS Achievement Award
Dr. Candice Silversides, a professor of medicine at the University of Toronto and a physician in the cardiology department of UHN, was presented with the CCS Achievement Award. This award is given to a researcher whose work has significantly aided the growth of and support to the cardiovascular field. She is Chair in Pregnancy and Heart Disease at the Miles Nadal Heart Centre at Mount Sinai Hospital, where she leads the Obstetric Medicine program and is director of the Cardio-Obstetric clinic. She also works at UHN, specializing in adult congenital heart disease and echocardiography and is vice president of the Canadian Adult Congenital Heart Network. Silversides’ research interests include pregnancy and heart disease and adult congenital heart disease. She has contributed to many international practice guidelines and consensus statements, including serving as chair of the Canadian Cardiovascular Society’s guidelines on the management of adults with congenital heart disease.
Congratulations to all winners on this significant career achievement, and we look forward to following your work in the future!
